FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
DATE OF REPORT: FEBRUARY 20, 1997
(Date of earliest event reported)
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 1-225 39-0394230
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
P.O. BOX 619100, DALLAS, TEXAS 75261-9100
(Address of principal executive offices) (Zip Code)
(972) 281-1200
(Registrant's telephone number, including area code)
Item 5. Other Events
Attached hereto as Exhibit 99 is the Business Segment Analysis for
Kimberly-Clark Corporation and its subsidiaries for the three months and
year ended December 31, 1996.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
KIMBERLY-CLARK CORPORATION
Date: February 20, 1997 By: /s/ John W. Donehower
-------------------------
John W. Donehower
Senior Vice President and
Chief Financial Officer
EXHIBIT INDEX
(99) Business Segment Analysis for Kimberly-Clark
Corporation and its subsidiaries for the three months
and year ended December 31, 1996
EXHIBIT 99
BUSINESS SEGMENT ANALYSIS
Kimberly-Clark Corporation and Subsidiaries
<TABLE>
<CAPTION>
Three Months Year
Ended December 31 Ended December 31
--------------------------- -----------------------------
(Millions of dollars) 1996 1995 Change 1996 1995 Change
- -------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
NET SALES:
Tissue-Based Products $1,832.1 $1,898.1 - 3.5% $ 7,372.8 $ 7,524.3 - 2.0%
Personal Care Products 1,235.9 1,077.6 14.7% 4,837.8 4,384.2 10.3%
Newsprint, Paper and Other 272.5 343.5 -20.7% 1,015.4 1,584.3 -35.9%
Intersegment sales (16.9) (21.3) N.M. (76.9) (119.8) N.M.
-------- -------- --------- ----------
Consolidated $3,323.6 $3,297.9 .8% $13,149.1 $ 13,373.0 -1.7%
======== ======== ========= ==========
</TABLE>
<TABLE>
<CAPTION>
Three Months Year
Ended December 31(a) Ended December 31(b)
--------------------------- -------------------------------
(Millions of dollars) 1996 1995(c) Change 1996 1995(c) Change
- ---------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
OPERATING PROFIT:
Tissue-Based Products $ 266.6 $ (796.6) N.M. $ 1,085.2 $ (38.4) N.M.
Personal Care Products 212.8 (82.5) N.M. 791.3 339.8 132.9%
Newsprint, Paper and Other 41.3 23.1 78.8% 211.8 224.6 -5.7%
Unallocated items - net 5.7 (231.9) N.M. (34.6) (313.0) N.M.
--------- --------- ---------- --------
Consolidated $ 526.4 $(1,087.9) N.M. $ 2,053.7 $ 213.0 864.2%
========= ========= ========== ========
</TABLE>
Notes: (a)Operating profit for the three months ended December 31, 1996
includes royalty expenses of consolidated subsidiaries for
Tissue-Based Products, Personal Care Products and Newsprint,
Paper and Other of $37.9 million, $5.6 million and $.1 million,
respectively, and corresponding royalty income for Unallocated
of $43.6 million. Operating profit for the three months ended
December 31, 1995 includes royalty expenses of consolidated
subsidiaries for Tissue-Based Products, Personal Care Products
and Newsprint, Paper and Other of $8.7 million, $13.6 million
and $.3 million, respectively, and corresponding royalty income
for Unallocated of $22.6 million.
(b) Operating profit for the year ended December 31, 1996
includes royalty expenses of consolidated subsidiaries for
Tissue-Based Products, Personal Care Products and Newsprint,
Paper and Other of $60.5 million, $22.6 million and $.3
million, respectively, and corresponding royalty income for
Unallocated of $83.4 million. Operating profit for the year
ended December 31, 1995 includes royalty expenses of
consolidated subsidiaries for Tissue-Based Products, Personal
Care Products and Newsprint, Paper and Other of $25.5 million,
$25.7 million and $1.5 million, respectively, and corresponding
royalty income for Unallocated of $52.7 million.
(c) Operating profit in 1995 for Tissue-Based Products, Personal
Care Products, Newsprint, Paper and Other and Unallocated
includes $981.2 million, $230.3 million, $35.0 million and
$193.5 million, respectively, of restructuring and other
unusual charges totaling $1,440.0 million.
N.M. - Not meaningful
Unaudited
